↓ Skip to main content

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017 - Volume 24, Number 2—February 2018 - Emerging Infectious Diseases journal - CDC

Overview of attention for article published in Emerging Infectious Diseases, February 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
15 news outlets
policy
2 policy sources
twitter
81 X users
facebook
3 Facebook pages
reddit
1 Redditor

Citations

dimensions_citation
123 Dimensions

Readers on

mendeley
78 Mendeley
Title
Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017 - Volume 24, Number 2—February 2018 - Emerging Infectious Diseases journal - CDC
Published in
Emerging Infectious Diseases, February 2018
DOI 10.3201/eid2402.171756
Pubmed ID
Authors

Brigitte Lefebvre, Irene Martin, Walter Demczuk, Lucie Deshaies, Stéphanie Michaud, Annie-Claude Labbé, Marie-Claude Beaudoin, Jean Longtin

Abstract

We identified a ceftriaxone-resistant Neisseria gonorrhoeae isolate in a patient in Canada. This isolate carried the penA-60 allele, which differs substantially from its closest relative, mosaic penA XXVII (80% nucleotide identity). Epidemiologic and genomic data suggest spread from Asia. Antimicrobial susceptibility surveillance helps prevent spread of highly resistant N. gonorrhoeae strains.

X Demographics

X Demographics

The data shown below were collected from the profiles of 81 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 15%
Student > Bachelor 11 14%
Student > Master 9 12%
Student > Doctoral Student 5 6%
Other 4 5%
Other 14 18%
Unknown 23 29%
Readers by discipline Count As %
Medicine and Dentistry 15 19%
Immunology and Microbiology 10 13%
Agricultural and Biological Sciences 8 10%
Biochemistry, Genetics and Molecular Biology 7 9%
Computer Science 2 3%
Other 12 15%
Unknown 24 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 173. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2023.
All research outputs
#233,519
of 25,382,440 outputs
Outputs from Emerging Infectious Diseases
#380
of 9,718 outputs
Outputs of similar age
#5,406
of 344,026 outputs
Outputs of similar age from Emerging Infectious Diseases
#6
of 115 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,718 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,026 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.